Publications

Drug delivery

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

31-12-2026

mAbs

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate.

01-12-2026

Health policy (Amsterdam, Netherlands)

Coverage with evidence development programs: a scoping review on characteristics and patient access.

01-09-2026

Clinical and translational radiation oncology

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

01-09-2026

Cancer discovery

A Counterintuitive Approach to Cancer Therapy.

03-08-2026

Breast (Edinburgh, Scotland)

Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnership.

01-08-2026

Annals of surgical oncology

ASO Author Reflections: Beyond Time to Diagnosis: The Lasting Impact of Diagnostic Experience in GIST.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

01-08-2026

The Lancet. Oncology

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

01-08-2026

Neuro-oncology practice

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

01-08-2026

Journal of cancer survivorship : research and practice

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

01-08-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

01-08-2026

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Prestin as a potential biomarker for cochlear injury: Current evidence and future directions.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

01-08-2026

Annals of surgical oncology

ASO Visual Abstract: Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.

01-08-2026

European radiology

Diagnostic assessment of artificial intelligence reconstruction on accelerated prostate MRI: a retrospective, paired, multi-reader multi-case study.

01-08-2026

Cancer epidemiology

Image-based consensus molecular subtypes and colon cancer recurrence: Understanding the impact of lifestyle factors across subtypes of colon cancer.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

01-08-2026

Annals of surgical oncology

Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.

01-08-2026

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Quality of life assessment for colorectal cancer follow-up: A latent profile analysis of EORTC measures.

01-08-2026

CPT: pharmacometrics & systems pharmacology

Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias.

01-08-2026

Tumori

Optimising combination therapy for paediatric, adolescent and young adult patients with non-rhabdomyosarcoma soft tissue sarcomas: The OCTOPUS platform trial.

30-07-2026

The FEBS journal

Inhibition of mitochondrial protein translation sensitizes tumor cells to death receptor 5 agonistic antibody.

29-07-2026

Cell reports

GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.

28-07-2026

Acta oncologica (Stockholm, Sweden)

The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

28-07-2026

Nature protocols

Three-dimensional tracking of dynamic structures in living cells using single-plane imaging with focus feedback.

28-07-2026

Oncogene

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

28-07-2026

Surgical endoscopy

Real-time surgical navigation for intraoperative lymph node localization during targeted robot-assisted pelvic and retroperitoneal lymph node dissection.

27-07-2026

Clinical pharmacokinetics

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

27-07-2026

European journal of cancer (Oxford, England : 1990)

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

26-07-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.

26-07-2026

Seminars in cancer biology

Beyond the traditional dish: Advanced 3D ex vivo culture platforms for tumor modelling.

24-07-2026

Journal of the National Cancer Institute

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

24-07-2026

European journal of cancer (Oxford, England : 1990)

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

22-07-2026

European journal of cancer (Oxford, England : 1990)

The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology.

22-07-2026

Cell reports methods

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4⁺ T cell help.

22-07-2026

Journal of occupational rehabilitation

Health- and Work-Related Outcomes in Partners of Cancer Survivors: A Prospective Cohort Study.

21-07-2026

European journal of nuclear medicine and molecular imaging

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

21-07-2026

Cell reports. Medicine

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

21-07-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

20-07-2026

Journal of occupational rehabilitation

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

20-07-2026

Journal of occupational rehabilitation

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

20-07-2026

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.

18-07-2026

Cancer treatment and research communications

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment.

18-07-2026

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.

16-07-2026

Cancer research

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

15-07-2026

Journal of cancer survivorship : research and practice

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

15-07-2026

Trends in cancer

Neoadjuvant immunotherapy in breast cancer: Progress and challenges.

15-07-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

13-07-2026

Cancer cell

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

13-07-2026

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate.

Coverage with evidence development programs: a scoping review on characteristics and patient access.

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

A Counterintuitive Approach to Cancer Therapy.

Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnership.

ASO Author Reflections: Beyond Time to Diagnosis: The Lasting Impact of Diagnostic Experience in GIST.

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Prestin as a potential biomarker for cochlear injury: Current evidence and future directions.

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

ASO Visual Abstract: Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.

Diagnostic assessment of artificial intelligence reconstruction on accelerated prostate MRI: a retrospective, paired, multi-reader multi-case study.

Image-based consensus molecular subtypes and colon cancer recurrence: Understanding the impact of lifestyle factors across subtypes of colon cancer.

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.

Quality of life assessment for colorectal cancer follow-up: A latent profile analysis of EORTC measures.

Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias.

Optimising combination therapy for paediatric, adolescent and young adult patients with non-rhabdomyosarcoma soft tissue sarcomas: The OCTOPUS platform trial.

Inhibition of mitochondrial protein translation sensitizes tumor cells to death receptor 5 agonistic antibody.

GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.

The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

Three-dimensional tracking of dynamic structures in living cells using single-plane imaging with focus feedback.

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

Real-time surgical navigation for intraoperative lymph node localization during targeted robot-assisted pelvic and retroperitoneal lymph node dissection.

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.

Beyond the traditional dish: Advanced 3D ex vivo culture platforms for tumor modelling.

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology.

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help.

Health- and Work-Related Outcomes in Partners of Cancer Survivors: A Prospective Cohort Study.

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

Development and validation of an LC-MS/MS method for the quantification of the KRASG12C inhibitor divarasib.

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment.

Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

Neoadjuvant immunotherapy in breast cancer: Progress and challenges.

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

This site uses cookies

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4⁺ T cell help.

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.